Enabling novel bioprocessing and quality control solutions.
New and improved solutions are required in the bioprocessing space to increase purity, yield and cost-efficiencies, and to facilitate the next generation of drug targets to be pursued through the pipeline. Optimer® binders, as fully optimised aptamers, are enabling these outcomes.
Working with expert partners across the industry Optimer® binders can be tuned to develop new bioprocesses for fragile targets with specific binding and elution conditions that maintain target functionality throughout affinity purification processes. With Optimer® binders’ broader target range generated through the three integrated discovery platform processes, we are working to improve quality control and biomanufacturing across multiple projects and target types to accelerate and support drug development for a wide range of human diseases.